Stock Research for ALNY

ALNY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALNY Stock Chart & Research Data

The ALNY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALNY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALNY Due diligence Resources & Stock Charts

The ALNY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALNY Detailed Price Forecast - CNN Money CNN View ALNY Detailed Summary - Google Finance
Yahoo View ALNY Detailed Summary - Yahoo! Finance Zacks View ALNY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALNY Trends & Analysis - Trade-Ideas Barrons View ALNY Major Holders - Barrons
NASDAQ View ALNY Call Transcripts - NASDAQ Seeking View ALNY Breaking News & Analysis - Seeking Alpha
Spotlight View ALNY Annual Report - CompanySpotlight.com OTC Report View ALNY OTC Short Report - OTCShortReport.com
TradeKing View ALNY Fundamentals - TradeKing Charts View ALNY SEC Filings - Bar Chart
WSJ View Historical Prices for ALNY - The WSJ Morningstar View Performance/Total Return for ALNY - Morningstar
MarketWatch View the Analyst Estimates for ALNY - MarketWatch CNBC View the Earnings History for ALNY - CNBC
StockMarketWatch View the ALNY Earnings - StockMarketWatch MacroAxis View ALNY Buy or Sell Recommendations - MacroAxis
Bullish View the ALNY Bullish Patterns - American Bulls Short Pains View ALNY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALNY Stock Mentions - StockTwits PennyStocks View ALNY Stock Mentions - PennyStockTweets
Twitter View ALNY Stock Mentions - Twitter Invest Hub View ALNY Investment Forum News - Investor Hub
Yahoo View ALNY Stock Mentions - Yahoo! Message Board Seeking Alpha View ALNY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALNY - SECform4.com Insider Cow View Insider Transactions for ALNY - Insider Cow
CNBC View ALNY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALNY - OTC Markets
Yahoo View Insider Transactions for ALNY - Yahoo! Finance NASDAQ View Institutional Holdings for ALNY - NASDAQ


Stock Charts

FinViz View ALNY Stock Insight & Charts - FinViz.com StockCharts View ALNY Investment Charts - StockCharts.com
BarChart View ALNY Stock Overview & Charts - BarChart Trading View View ALNY User Generated Charts - Trading View




Latest Financial News for ALNY


ALNYLAM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alnylam Pharmaceuticals, Inc. To Contact The Firm
Posted on Thursday September 20, 2018

NEW YORK , Sept. 20, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities claims against Alnylam Pharmaceuticals, Inc.   ("Alnylam" ...


See what the IHS Markit Score report has to say about Alnylam Pharmaceuticals Inc.
Posted on Thursday September 20, 2018

Alnylam Pharmaceuticals Inc NASDAQ/NGS:ALNY


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
Posted on Tuesday September 18, 2018

NEW YORK, NY / ACCESSWIRE / September 18, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. ("Alnylam" or the "Company") (ALNY). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation concerns whether Alnylam and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.


What Solid Biosciences’ Valuation Trend Indicates
Posted on Friday September 14, 2018

Solid Biosciences (SLDB) incurred a net loss of $17.98 million in the second quarter of 2018, which compares to a net loss of $11.31 million in the second quarter of 2017, translating to a net loss per share of $0.52 in the second quarter of 2018. Its net loss per share was $0.66 in the second quarter of 2017. The decrease in net loss per share was due to an increase in the company’s outstanding shares, which increased from 17.04 million in the second quarter of 2017 to 34.45 million in the second quarter of 2018.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.